Edwards Lifesciences Narrows Full-Year Sales Outlook After Second-Quarter Growth

Stocks Yahoo Finance By Yahoo Finance 23 Jul 2026 21:17 1 min read
Edwards Lifesciences Narrows Full-Year Sales Outlook After Second-Quarter Growth

Covered in this story

What has happened since

Price move measured from the close nearest publication to the latest quote.

Analyst targets on Edwards Lifesciences

Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.

Call it yourself

No member calls on $EW yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Edwards Lifesciences →

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance.